OLVIG
TDOC icon

Oliver Lagore Vanvalin Investment Group’s Teladoc Health TDOC Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30
Closed -$275 – 731
2024
Q3 		$275 Hold
30
– – ﹤0.01% 637
2024
Q2 		$293 Hold
30
– – ﹤0.01% 677
2024
Q1 		$453 Hold
30
– – ﹤0.01% 671
2023
Q4 		$647 Hold
30
– – ﹤0.01% 682
2023
Q3 		$558 Hold
30
– – ﹤0.01% 766
2023
Q2 		$760 Sell
30
-400
-93% -$10.1K ﹤0.01% 704
2023
Q1 		$11.1K Sell
430
-600
-58% -$16.1K ﹤0.01% 373
2022
Q4 		$24.4K Hold
1,030
– – 0.01% 246
2022
Q3 		$26K Buy
1,030
+500
+94% +$17.5K 0.02% 228
2022
Q2 		$18K Buy
530
+150
+39% +$6.37K 0.01% 269
2022
Q1 		$27K Buy
+380
New +$27.4K 0.02% 227

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's TDOC Position: Q4 2024 in Review

Oliver Lagore Vanvalin Investment Group sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 30 shares — an estimated $275 sold.

Oliver Lagore Vanvalin Investment Group first reported a position in TDOC in Q1 2022 and held it in 11 quarters. The position peaked at $27K in Q1 2022. 381 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

  • Oliver Lagore Vanvalin Investment Group reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 30 Teladoc Health shares in Q4 2024, an estimated $275.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Teladoc Health in Q1 2022 and held it in 11 quarters.
  • Oliver Lagore Vanvalin Investment Group's Teladoc Health position peaked at $27K in Q1 2022.
  • 381 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q4 2024, filed 1 Apr 2025.